These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10524657)

  • 1. Serotonin infusions inhibit sensory input from the dural vasculature.
    Lambert GA; Shimomura T; Boers PM; Gordon V; Donaldson C; Zagami AS
    Cephalalgia; 1999 Sep; 19(7):639-50. PubMed ID: 10524657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 5HT in migraine.
    Buzzi MG
    Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
    Storer RJ; Goadsby PJ
    Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
    Goadsby PJ; Hoskin KL
    Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropharmacology; 2001 Mar; 40(4):520-5. PubMed ID: 11249961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
    Goadsby PJ; Knight Y
    Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate.
    Lambert GA; Boers PM; Hoskin KL; Donaldson C; Zagami AS
    Brain Res; 2002 Oct; 953(1-2):181-8. PubMed ID: 12384251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cortical spreading depression on activity of trigeminovascular sensory neurons.
    Lambert GA; Michalicek J; Storer RJ; Zagami AS
    Cephalalgia; 1999 Sep; 19(7):631-8. PubMed ID: 10524656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenic vs vascular mechanisms of sumatriptan and ergot alkaloids in migraine.
    Edvinsson L
    Cephalalgia; 1998 Jan; 18(1):5. PubMed ID: 9601617
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM
    Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
    Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor antagonists discriminate between PKA- and PKC-mediated plasticity in aplysia sensory neurons.
    Dumitriu B; Cohen JE; Wan Q; Negroiu AM; Abrams TW
    J Neurophysiol; 2006 Apr; 95(4):2713-20. PubMed ID: 16236785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
    Akerman S; Holland PR; Hoffmann J
    Cephalalgia; 2013 Jun; 33(8):577-92. PubMed ID: 23671254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater.
    Bartsch T; Goadsby PJ
    Brain; 2003 Aug; 126(Pt 8):1801-13. PubMed ID: 12821523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats.
    Avila-Rojas SH; Velázquez-Lagunas I; Salinas-Abarca AB; Barragán-Iglesias P; Pineda-Farias JB; Granados-Soto V
    Brain Res; 2015 Oct; 1622():377-85. PubMed ID: 26168890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.